• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC QDOT MICRO¿ CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC QDOT MICRO¿ CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Catalog Number D139505
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/23/2023
Event Type  malfunction  
Event Description
It was reported that a patient underwent a cardiac ablation procedure with a qdot micro¿ catheter during a manufacturing investigation, a lack of adhesive on the anchorage section of the tip was observed.Initially, it was reported that after the catheter was inserted into the patient's body, the contact force (cf) rises on its own, even after obtaining 0.The cable was replaced, and the issue did not resolve.After replacing the qdot catheter with a new one, the problem was resolved, and the procedure was completed.There was no patient consequence.An ngen generator software ver,2.0.27.61 was used.No other generator was used.The force issue was assessed as non mdr reportable.The potential risk that it could cause or contribute to a serious injury or death to the operator or patient was remote.The biosense webster, inc.Product analysis lab received the device for evaluation and per the evaluation completion on 02-nov-2023, a lack of adhesive on the anchorage section of the tip was observed.The insufficient adhesive was assessed as mdr reportable.The awareness date for this reportable lab finding was 02-nov-2023.
 
Manufacturer Narrative
E 1.Initial reporter phone: (b)(6).The device was returned to biosense webster (bwi) for evaluation.Visual inspection and screening test of the returned device were performed following bwi procedures.Visual analysis revealed no damage or anomalies on the device.A screening test was performed, and the device was visualized and recognized correctly; however, during the testing, the catheter was deflected showing high force values and the negative force vector.Due to this, a manufacturing investigation was performed and lack of adhesive on the anchorage section of the tip was observed.An awareness session was performed to avoid this type of issues.A manufacturing record evaluation was performed for the finished device 31043591l number, and no internal actions related to the reported complaint condition were identified.The issue reported by the customer was confirmed.It should be noted that product failure is multifactorial.The instructions for use contain the following information that should be considered: to ensure accurate force readings, verify that the force reading is near zero when the catheter is not in contact with tissue.If the force reading is not near zero when the catheter is not in contact with tissue, perform zeroing.As part of biosense webster's quality process, all devices are manufactured, inspected, and released to approved specifications.This product issue will be addressed through bwi's quality system.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: pc-(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QDOT MICRO¿ CATHETER
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key18234577
MDR Text Key330122704
Report Number2029046-2023-02779
Device Sequence Number1
Product Code OAE
UDI-Device Identifier10846835016758
UDI-Public10846835016758
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P210027
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other
Type of Report Initial
Report Date 11/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberD139505
Device Lot Number31043591L
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/05/2023
Initial Date Manufacturer Received 11/02/2023
Initial Date FDA Received11/29/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/18/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NGEN GENERATOR; UNK BRAND CABLE; UNK BRAND CABLE
-
-